High BMI raises risk of cardiotoxicity for breast cancer patients undergoing chemotherapy

A recent study based in the North-East region of Columbia found that a high body mass index (BMI) was linked to heart damage or cardiotoxicity during chemotherapy. The study will be presented at the American College of Cardiology Latin America 2023 Together with Asociación Costarricense de Cardiología (11−12 August, San Jose, Costa Rica). Breast cancer survival rates are improving considerably in Colombia. Despite this, factors that increase the likelihood of adverse events during chemotherapy, such as cardiotoxicity, are not fully elucidated in previous literature. With cardiotoxicity emerging as a relatively recent concern in cancer care, its recognition as a significant...